Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Umeclidinium and vilanterol

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing
    U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226303/0/en/Transpire-Bio-s-ANDA-for-Generic-Trelegy-Ellipta-Accepted-for-Filing-by-the-U-S-FDA.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Transpire Bio's Generic Breo Ellipta Anda Accepted By Us FDA
    Transpire Bio's Generic Breo Ellipta Anda Accepted By Us FDA

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154541/0/en/Transpire-Bio-s-ANDA-for-Generic-Breo-Ellipta-Accepted-for-Filing-By-the-U-S-FDA.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids
    GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids

    27 Aug 2020

    // PINKSHEET

    https://pink.pharmaintelligence.informa.com/PS142810/GSKs-Trelegy-Ellipta-US-FDA-Panel-To-Weigh-Role-Of-Inhaled-Corticosteroids-On-Mortality-Results

    PINKSHEET
    27 Aug 2020
    Share Share
    GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma
    GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma

    27 Feb 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200227005586/en

    BUSINESSWIRE
    27 Feb 2020
    Share Share
    Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
    Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs

    01 Jan 2020

    // Michael Erman CNBC

    https://www.cnbc.com/2019/12/31/reuters-america-exclusive-drugmakers-from-pfizer-to-gsk-to-hike-u-s-prices-on-over-200-drugs.html

    Michael Erman CNBC
    01 Jan 2020
    Share Share
    GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma
    GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma

    03 Oct 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191002005525/en

    BUSINESSWIRE
    03 Oct 2019
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.